Scenarios | ALE (years) | Gain in ALE relative to Base scenario (years) | ||
---|---|---|---|---|
Women | 95 % CI | Women | 95 % CI | |
Base scenario | 33.16 | 32.82,33.50 | - | - |
0 % prevalence <30 years | 33.31 | 32.95, 33.69 | 0.15 | 0.13,0.17 |
10 % prevalence <30 years* | 33.28 | 32.92, 33.65 | 0.12 | 0.10,0.15 |
0 % prevalence <40 years | 33.50 | 33.12, 33.85 | 0.34 | 0.30,0.36 |
10 % prevalence <40 years | 33.38 | 33.00, 33.71 | 0.21 | 0.18,0.22 |
0 % prevalence <50 years | 33.65 | 33.23,34.28 | 0.48 | 0.45,0.5 |
10 % prevalence <50 years | 33.45 | 33.07, 33.78 | 0.26 | 0.24,0.28 |
0 % prevalence <60 years | 33.75 | 33.34,34.18 | 0.59 | 0.51,0.68 |
10 % prevalence <60 years | 33.45 | 33.09, 33.81 | 0.29 | 0.27,0.31 |
0 % prevalence <70 years | 33.83 | 33.44,34.22 | 0.66 | 0.62,0.72 |
10 % prevalence <70 years | 33.45 | 33.09, 33.81 | 0.29 | 0.27,0.31 |
0 % prevalence <80 years | 33.88 | 33.54,34.22 | 0.71 | 0.7,0.72 |
10 % prevalence <80 years | 33.44 | 33.07, 33.78 | 0.27 | 0.25,0.29 |
10 % prevalence in entire population | 33.43 | 33.41, 33.47 | 0.27 | −0.03 ,0.59 |
0 % prevalence in entire population | 33.90 | 33.54,34.24 | 0.73 | 0.72,0.74 |